Literature DB >> 16023102

Specific transport of S-nitrosocysteine in human red blood cells: Implications for formation of S-nitrosothiols and transport of NO bioactivity within the vasculature.

Jörg Sandmann1, Kathrin S Schwedhelm, Dimitrios Tsikas.   

Abstract

The transport of various S-nitrosothiols, NO and NO donors in human red blood cells (RBC) and the formation of erythrocytic S-nitrosoglutathione were investigated. Of the NO species tested only S-nitrosocysteine was found to form S-nitrosoglutathione in the RBC cytosol. L-Serine, L-cysteine and L-lysine inhibited formation of S-nitrosoglutathione. Incubation of RBC pre-incubated with S-[15N]nitroso-L-cysteine with native plasma or platelet-rich plasma led to formation of S-[15N]nitrosoalbumin and inhibited platelet aggregation, respectively. The specific transporter system of S-nitroso-L-cysteine in the RBC membrane may have implications for formation of S-nitrosoalbumin and S-nitrosohemoglobin and for transport of NO bioactivity within the vasculature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023102     DOI: 10.1016/j.febslet.2005.06.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking.

Authors:  Kentaro Ozawa; Erin J Whalen; Christopher D Nelson; Yuanyu Mu; Douglas T Hess; Robert J Lefkowitz; Jonathan S Stamler
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

Review 2.  S-nitrosothiols as selective antithrombotic agents - possible mechanisms.

Authors:  M P Gordge; F Xiao
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

3.  Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols.

Authors:  Taiming Liu; Hobe J Schroeder; Sean M Wilson; Michael H Terry; Monica Romero; Lawrence D Longo; Gordon G Power; Arlin B Blood
Journal:  Free Radic Biol Med       Date:  2015-12-12       Impact factor: 7.376

Review 4.  Role of Erythrocytes in Nitric Oxide Metabolism and Paracrine Regulation of Endothelial Function.

Authors:  Damian Gajecki; Jakub Gawryś; Ewa Szahidewicz-Krupska; Adrian Doroszko
Journal:  Antioxidants (Basel)       Date:  2022-05-11

Review 5.  Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation.

Authors:  Barry W Allen; Jonathan S Stamler; Claude A Piantadosi
Journal:  Trends Mol Med       Date:  2009-09-24       Impact factor: 11.951

Review 6.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

Review 7.  Red Blood Cell-Mediated S-Nitrosohemoglobin-Dependent Vasodilation: Lessons Learned from a β-Globin Cys93 Knock-In Mouse.

Authors:  Richard T Premont; James D Reynolds; Rongli Zhang; Jonathan S Stamler
Journal:  Antioxid Redox Signal       Date:  2020-07-23       Impact factor: 8.401

8.  Extra-platelet low-molecular-mass thiols mediate the inhibitory action of S-nitrosoalbumin on human platelet aggregation via S-transnitrosylation of the platelet surface.

Authors:  Dimitrios Tsikas
Journal:  Amino Acids       Date:  2021-02-14       Impact factor: 3.520

9.  The role of red blood cell S-nitrosation in nitrite bioactivation and its modulation by leucine and glucose.

Authors:  Nadeem Wajih; Xiaohua Liu; Pragna Shetty; Swati Basu; Hanzhi Wu; Neil Hogg; Rakesh P Patel; Cristina M Furdui; Daniel B Kim-Shapiro
Journal:  Redox Biol       Date:  2016-04-30       Impact factor: 11.799

Review 10.  S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)-Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H2S and GSH suppliers and as antioxidants: Results and overview.

Authors:  Dimitrios Tsikas; Kathrin S Schwedhelm; Andrzej Surdacki; Daniela Giustarini; Ranieri Rossi; Lea Kukoc-Modun; George Kedia; Stefan Ückert
Journal:  J Pharm Anal       Date:  2017-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.